ArticleFrontiers in bioinformatics2026
Mutation-induced heme pocket destabilization in myoglobinopathy.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Myoglobin (Mb) is a heme-binding protein essential for oxygen storage, transport, and redox regulation, governed by a finely tuned network of electrostatic and hydrogen bonding interactions within the heme pocket. A point mutation His97Tyr leads to a hereditary disease, myoglobinopathy which disrupts heme-propionate interactions and leads to protein aggregation. Previous structural studies relied on a crystallographic model in which a Lys45Arg substitution was introduced to stabilize the heme pocket, masking the effects of the His97Tyr mutation and preventing clear interpretation of its role. Methods: To resolve this, we performed classical molecular dynamics simulations to systematically dissect the individual and combined structural effects of residues 45 and 97 by comparing the His97Tyr mutation in the native Lys45 (wild-type) and the crystallographic Arg45 residue. Results: Our results show that residue 45 plays a dominant role in regulating long-range dynamical networks, with Arg45 producing more spatially coherent correlations than the diffuse dynamics observed in the wild-type Lys45 protein. Structural variability within the heme pocket is primarily driven by redistribution of heme-propionates, where residue 45 acts as the main determinant, while residue 97 contributes an additive effect. Although iron coordination remains preserved across all systems, the wild-type His97Tyr variant exhibits tilting of the heme group within the pocket, indicating increased conformational flexibility. Discussion: Together, these findings suggest that the disease-associated mutation alters heme dynamics and highlights the critical role of sequence context in interpreting mutation-driven changes in myoglobin structure and function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.